TRI Treatment Research Institute: Science Over Addiction

PUBLICATIONS

From the Clinical Trials Network
Refereed Journal Articles (continued)
Ling, W., Amass, L., Shoptaw, S., Annon, J.J., Babcock, D., Brigham, G.,Harrer, J., Reid, M., Buchan, B., Orr, D., Woody, G., Krejci, J., Ziedonis, D., and the buprenorphine study protocol group. A Multi Center Randomized Trial Of Buprenorphine-Naloxone and Clonidine for Opioid Detoxification: Findings from the National Institute On Drug Abuse. Addiction. 1090-1100,2005.

Liu, Y, Wang, X, Douglas' SD, Metzger DS, Woody G, Zhang'T, Song- L, Ho1'W-Z. CD8+ T Cell Depletion Amplifies Hepatitis C Virus Replication in Peripheral Blood Mononuclear Cells. J. Infectious Dis. 192: 1092-1101, 2005.

McLellan AT., Cacciola J., Carise D., Alterman A.I. (2005) The ASI at 25: A Review of Findings, Problems and Possibilities. American Journal on Addictions.

McLellan AT., McKay J.R., Forman R., Cacciola J., Kemp J. (2005) Reconsidering the Evaluation of Addiction Treatment: From Retrospective Follow-Up to Concurrent Recovery Monitoring. Addiction. 100:447-458.

McLellan A. T., Weinstein R.L., Shen Q., Kendig C. and Levine M. (2005) Improving continuity of care in a public addiction treatment system with clinical case management. Am. J. Addiction.

Pechansky, F., Woody, G., Inciardi, J., Surratt, H., Kessler, F., Von Diemen, L., Bumaguin, D.B. HIV seroprevalence rates of Brazilian drugusers: an analysis of selected variables based on ten years of data collection. Drug and Ale. Dep., 82 Suppl:S109-113, 2006.

Philip T. Ninan, P.T., Koran, L.M., Kiev, A., Davidson, J.R.T., Rasmussen, S.A., Zajecka, J., Robinson, D.G., Crits-Christoph, P., Mandel, F.S., Austin, C. (in press). High dose sertraline strategy for non-responders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. Journal of Clinical Psychiatry.

Simeone R., McLellan AT. and Carise D. (2005) The Reliability and Validity of Retrospective Self-Reported Drug Use. Journal of Medical Statistics.

Smith, MY, Dart R, Hughes A, Geller A, Senay E, Woody G, Colucci S. Clinician Validation of Poison Control Center (PCC) Intentional Exposure Cases Involving Prescription Opioids. Am J Drug & Alcohol Abuse. Vol. 32(3), 2006 (In press).

Smith, MV, Woody, GE. Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms and psychiatric disorders: patterns, user characteristics, and management options. Current Psychiatry Rep. Friedel, R.O and Evans, D.L. (Eds). 7(5):337-343, 2005.
Thompson, R., Kane, V., Cook, J., Walker, P., Greenstein, R., & Woody, G.E. Predictors of suicidal ideation in patients receiving methadone maintenance. J. Psychoactive Drugs. In press, 2006.

Tu, X.M., Kowalski, J., Crits-Christoph, P., & Gallop, R. (in press). Power Analyses for Correlations from Clustered Study Designs. Statistics in Medicine.
Woody, G.E. New Horizons: Sustained release morphine for agonist treatment. Addiction. 100; 1758-1759,2005.

Zajecka, J., Robinson, D.G., Crits-Christoph, P., Mandel, F.S., Austin, C. (in press). High dose sertraline strategy for non-responders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. Journal of Clinical Psychiatry.

Ziedonis, D.M., Amass, L, Steinberg, M.L., Krejci, J., Woody, G, et al.Predictors of Outcome for Short-Term Medically Supervised Opioid Withdrawal During a Randomized, Multi Center Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network. Under review, 2006.